Annexon (ANNX) Non Operating Income (2021 - 2026)

Annexon's (ANNX) quarterly Non Operating Income came in at $1.9 million in Q1 2026, down 37.32% year-on-year from $3.0 million in Q1 2025, and down 4.55% quarter-over-quarter from $2.0 million in Q4 2025.

Annexon (ANNX) Non Operating Income (2021 - 2026) Analysis & Trends

Annexon's Non Operating Income history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 37.32% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $8.6 million, a 44.74% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 38.78% from the prior year.
  • Non Operating Income declined to $1.9 million in Q1 2026 per ANNX's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.6 million in Q3 2024 and bottomed at $53000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $2.3 million (2022), against an average of $2.4 million.
  • Across the five-year window, Non Operating Income tumbled 62.68% in 2022 and soared 4741.51% in 2023, its largest moves.
  • Year by year, Non Operating Income stood at $2.3 million in 2022, then slipped by 8.39% to $2.1 million in 2023, then soared by 83.62% to $3.9 million in 2024, then slumped by 48.52% to $2.0 million in 2025, then slipped by 4.55% to $1.9 million in 2026.
  • Per Business Quant, the three latest ANNX Non Operating Income figures stand at $1.9 million (Q1 2026), $2.0 million (Q4 2025), and $2.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Annexon 1.03 Bn 804.24 Mn - 1.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.91 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 2.57 Mn
Mar 31, 2025 3.05 Mn
Dec 31, 2024 3.89 Mn
Sep 30, 2024 4.62 Mn
Jun 30, 2024 3.97 Mn
Mar 31, 2024 3.40 Mn
Dec 31, 2023 2.12 Mn
Sep 30, 2023 2.30 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.57 Mn
Dec 31, 2022 2.31 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 272,000.00
Mar 31, 2022 53,000.00
Dec 31, 2021 87,000.00
Sep 30, 2021 82,000.00
Jun 30, 2021 79,000.00